Back to Search Start Over

Seizure outcome after epilepsy surgery in tuberous sclerosis complex: Results and analysis of predictors from a multicenter study.

Authors :
Vannicola, C.
Tassi, L.
Barba, C.
Boniver, C.
Cossu, M.
de Curtis, M.
De Palma, L.
D'Errico, I.
Didato, G.
Guerrini, R.
La Briola, F.
Luisi, C.
Mai, R.
Mari, F.
Marras, C.
Mastrangelo, M.
Peron, A.
Specchio, N.
Toldo, I.
Turner, K.
Source :
Journal of the Neurological Sciences. Aug2021, Vol. 427, pN.PAG-N.PAG. 1p.
Publication Year :
2021

Abstract

Epilepsy surgery is recommended in selected patients with Tuberous Sclerosis Complex (TSC). However, reports on predictive factors of seizure outcome are variable. Here we report on seizure and cognitive outcome of 35 TSC patients who received surgery for refractory epilepsy in 7 Italian centers over a period of 22 years (1997–2019). The rate of seizure-free individuals at last follow-up (mean 7.5 years, range 1–21 years) was 51%. Patients with longer follow-up (≥10 years) had a lower rate of Engel I outcome (11.1%) than those who received surgery in the last 10 years (65.4%, p = 0.003). Factors associated with Engel II, III, IV outcome in our cohort included: high number of cortical tubers (≥5); presence of subependymal nodules (SENs); seizure onset before age 1 year; and multifocal interictal epileptic discharges (IEDs) on electroencephalogram (EEG). A subset of patients evaluated with Vineland Adaptive Behaviour Scales (VABS) showed developmental gains, in line with their developmental trajectories, but no improvement in standard scores after surgery was noted. Our study demonstrates that the rates of successful seizure outcome of epilepsy surgery in TSC have improved in the last 10 years. More than half of the patients achieved seizure freedom, and a high proportion of affected individuals experienced a reduction in seizure burden and in antiseizure medications. A comprehensive assessment after surgery should be performed in TSC patients to evaluate the overall neurodevelopmental outcome, as measures that are based only on seizure control do not adequately identify the benefits of surgery on global functioning in these patients. • Epilepsy surgery is a treatment option for patients with refractory seizures in TSC. • More than half of the patients who received surgery achieved seizure freedom. • A worthwhile improvement is observed in up to 77% of surgically treated patients. • Multiple tubers, early seizure onset and multifocal IEDs predict seizure recurrence. • Presurgical assessment is crucial to selecting best candidates for surgery. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
0022510X
Volume :
427
Database :
Academic Search Index
Journal :
Journal of the Neurological Sciences
Publication Type :
Academic Journal
Accession number :
151607676
Full Text :
https://doi.org/10.1016/j.jns.2021.117506